Adobe

01 / The central investment debate

The opportunity: Adobe remains the paid workflow for professional creation, documents and marketing while AI improves its tools. The risk: cheaper generation and automation reduce paid seats and pricing power, while a larger free audience raises computing costs. More users or content do not necessarily mean more profit.[S2][S7]

Q3 revenue grew 12.9%, but GAAP operating margin fell to 34.8% from 36.3%. Net income grew only 3.1%; share retirement lifted EPS growth to 10.5%. The investment test is paid recurring demand and cash profitability—not buyback-supported EPS alone.[S1]

Consensus is a third-party estimate, not guidance. No FY2027 management guidance or reliable public FCF consensus was verified in the original research. Valuation below uses GAAP earnings, including stock-based compensation (SBC), rather than adjusted EPS.[S1][S14]

02 / Competitive position

Adobe’s defensible assets are professional skills, editing precision, shared files, approvals and enterprise integrations. Its most exposed customers are casual creators who need an acceptable result rather than a complete production workflow. Canva, Figma and AI tools challenge that segment; Microsoft and Salesforce add distribution and bundling pressure.[S2][S7]

Peer quarters end June–August 2026; cash yields use the original report’s trailing data and market values, except Figma’s half-year observation. Growth is reported, not uniformly organic: Salesforce includes Informatica and Adobe includes Semrush. Microsoft is not a pure creative-software peer, and heavy infrastructure capex reduces its cash yield. These are not interchangeable businesses.[S1][S15][S16][S17][S18][S19][S20][S22][S23][S24][S25]

AI-first ARR exceeded $650m, but was only about 2.4% of Adobe’s $27.5bn total ARR at that lower bound. It is already included in total ARR. The base case needs about $10.2bn of additional annual revenue by FY2031; a growing free funnel cannot carry that forecast without paid conversion and expansion of the existing franchise.[S6][S7]

03 / Earnings are not distributable cash

Over FY2021–25, revenue compounded at 10.8%, GAAP EPS at 13.6% and FCF at 9.4%. FY2024 included the $1bn Figma termination payment: exclude it when judging recurring growth, but not when judging capital allocation.[S2][S3]

Trailing twelve months to August 2026. Aggregate yields use the original $103.75bn vendor market capitalisation; share-count dates and definitions differ from the EPS model. Figures above overlap and must not be added.[S1][S2][S4][S5][S22]

Capital return: gross shareholder yield is about 9.0%; the net economic proxy is about 7.0% after SBC, versus an observed 6.8% year-on-year reduction in quarterly diluted shares. These are different measures. FY2025 buybacks exceeded FCF ($11.28bn versus $9.85bn), so that spending pace is not assumed indefinitely.[S1][S2]

Financial resilience: $5.64bn of cash/investments offsets $6.36bn of debt; net financial debt is only $0.72bn, with another $0.40bn of operating leases. Physical capex is 0.8% of trailing revenue, but R&D and hosting are real costs. Modelled FY2025 ROIC falls from 58.5% to roughly 38.5% when R&D is capitalised analytically; public filings do not establish incremental product-level returns.[S1][S2][S4]

04 / Our five-year operating scenarios

These are independent assumptions, not management forecasts. The bear case assumes creative/marketing contraction; the base case assumes mid-single-digit growth and modest margin improvement; the bull case requires successful AI monetisation without losing professional pricing power.

Buybacks are already included in EPS. Returns are terminal value ÷ purchase price, raised to ⅕, minus one. No buyback yield is added again; dividends are zero. The flat-multiple row holds today’s approximately 14.2× forward GAAP P/E unchanged.

Repurchases are cash-funded and offset by SBC-equivalent dilution. The base case allocates 80% of FCF to gross buybacks at a 16× execution P/E; the terminal valuation is separately 18×. Higher repurchase prices explain the bull case’s smaller share retirement. The bear outcome is not a maximum-loss estimate.

05 / The base-case path

Revenue compounds at 6.7% and net income at 7.5%; falling shares lift EPS growth to 13.4%. FCF per share grows 11.9%. FY2027 includes an assumed 1.5% extra-week benefit and $180m of acquisition rollover, not repeatable organic growth; the calendar uplift reverses in FY2028.[S2][S21]

DCF deducts current net financial debt once and uses current shares, not the shrinking forecast denominator. Full cash-funding, annual scenario and valuation schedules remain in the companion Excel workbook.

06 / Back-solving the 20% hurdle

At 18×, the required $35.63 EPS is 4.7% above the $34.04 base case. Holding base revenue and shares fixed requires 38.2% operating margin rather than 36.5%. Alternatively, base earnings need an 18.84× exit P/E.

The cash-flow test is similar: at 13× terminal FCF, the hurdle requires $49.34 FCF per share, or $15.10bn total FCF versus $14.21bn in the base case. That means 7.3% total FCF CAGR, using the model’s $10.6bn FY2026 anchor—not company guidance.

The entry-price alternative: $612.65 ÷ 1.20⁵ = $246.21. Below that price, the unchanged base forecast clears 20%; it does not remove operating risk.

Company repurchase prices and operating assumptions are held constant across entry prices. All returns are five-year USD CAGRs before tax, fees and currency effects, not an expectation of 20% in every calendar year.

07 / What would confirm or break the thesis?

The next earnings reports must demonstrate paid demand and cash economics, not just larger user counts. These are analyst monitoring thresholds; judge repeated deterioration rather than one quarter’s timing.

Paid conversion and AI cohort profitability remain incompletely disclosed. ARR growth must be adjusted for acquisitions and currency where possible; “organic-like” is not a company-certified organic measure.[S1][S6][S7][S21]

Q4 results, listed for 9 December 2026 in the original research, are the next major test: roughly $777m of net-new ARR is needed to meet the current annual target, alongside credible FY2027 guidance stripped of calendar and acquisition effects.[S6][S12]

08 / Conclusion and limitations

At $257.76: attractive cash economics, but not a proven 20% intrinsic compounder. The cleaner planning assumption is low-teens per-share growth; returns approaching 20% also depend on a favourable entry price or higher terminal valuation.

Risk/reward improves around $220–240, below the $246 mathematical hurdle and the $288 DCF cross-check. That conclusion holds only while paid demand, margins and cash generation support the forecast. A cheaper share price caused by a weaker franchise requires a new model—not blind reliance on the old threshold.

AI-driven seat compression, inference costs and poor capital allocation can damage growth and valuation together. This condensed edition retains the original 16 September 2026 data and model assumptions; it is an editorial revision, not a market-data refresh. Source-backed actuals are distinct from uncertain long-run forecasts. The model is not an audited three-statement forecast or an exact-date cash-flow return calculation. General research, not personalised financial advice.